Cell Culture Plates Global Market Report 2024

The cell culture plates market size has grown strongly in recent years. It will grow from $2.16 billion in 2023 to $2.28 billion in 2024 at a compound annual growth rate (CAGR) of 5.2%. The growth observed in the historical period can be attributed to several factors, including the expansion of biopharmaceutical research, a rising incidence of chronic diseases, notable advancements in cell biology, increased emphasis on drug screening and toxicology studies, and the proliferation of academic and industrial research activities. These elements collectively contributed to the growth witnessed within that timeframe in the field of cell culture plates and related technologies.

The cell culture plates market size is expected to see strong growth in the next few years. It will grow to $2.8 billion in 2028 at a compound annual growth rate (CAGR) of 5.3%. The anticipated growth in the forecast period can be attributed to several key factors, notably the ascent of personalized medicine, the widening scope of stem cell research, the expanding biotechnology industry, a shift towards 3D cell culture techniques, and the increased adoption of automation and high-throughput screening methodologies. Key trends expected in the forecast period encompass heightened utilization of coated and functionalized plates, a concentrated focus on compatibility with automation and robotics, the incorporation of advanced materials in plate manufacturing, and an emphasis on sustainable and biodegradable materials. These trends collectively contribute to the projected growth within this period in the domain of cell culture plates and associated technologies.

The anticipated rise in the prevalence of chronic diseases is expected to be a significant driver propelling the growth of the cell culture plates market. Chronic diseases, which endure for a year or longer and require ongoing medical care, significantly impact individuals' daily activities. Cell culture plates play a crucial role in addressing this healthcare challenge by providing optimal conditions for cell culture, combining various cell types in integrated and self-organized systems. These plates facilitate research and development efforts focused on understanding disease progression, testing new treatments, and assessing drug performance. In September 2022, the World Health Organization reported that 74% of the 41 million global deaths each year result from non-communicable diseases (NCDs) or chronic diseases. Notably, 17.9 million deaths were attributed to cardiovascular diseases, 9.3 million to cancer, 4.1 million to chronic respiratory diseases, and 2.0 million to diabetes. The rising prevalence of chronic diseases stands as a key driver fueling the growth of the cell culture plates market.

The expanding biotechnology sector is poised to drive the growth of the cell culture plates market. The biotechnology sector, characterized by its interdisciplinary nature that integrates biology, chemistry, genetics, and microbiology, relies heavily on cell culture plates as indispensable tools. These plates support a wide range of applications, fostering continuous advancements and innovation within the biotechnology field. According to the Biotechnology Innovation Organization, the bioscience sector in the United States employed 2.1 million people in over 127,000 U.S. businesses in 2021. The sector's economic contribution to the U.S. economy in 2021 amounted to $2.9 trillion. Additionally, there was an 11% increase in employment from 2018 to 2019 within the biosciences sector. This robust growth in the biotechnology sector underscores the pivotal role of cell culture plates in supporting various applications, contributing to the sector's ongoing success, and driving the overall growth of the cell culture plates market.

Product innovation has become a prominent and increasingly popular trend in the cell culture plates market, with major companies actively developing innovative products to bolster their market positions. A notable instance is Porvair Sciences, a UK-based manufacturer of microplates and microplate instrumentation, which, in April 2022, introduced the Sero Krystal PDL-coated microplate. This product is designed to enhance cell adhesion, growth, and proliferation in serum-free media across various cell types. The Sero Krystal PDL microplates, available in 96- and 384-well configurations, feature an even coating with a 70–150 kDa Poly-D-Lysine (PDL) polymer, achieved through unique processes. The coating creates a homogeneous net positive charge on the plate well surface, contributing to improved cell culture conditions.

Major players in the cell culture plates market are directing their efforts towards developing advanced products, particularly in the realm of 3D Cell Culture Plates, to fortify their market positions. 3D cell culture plates address the demand for advanced and physiologically relevant models, making significant contributions across diverse research and development applications. In August 2021, Amerigo Scientific, a US-based distribution company, introduced the Launch of 3D Cell Culture for Scientific Uses. Amerigo Scientific's 3D platforms offer more physiological conditions for cell culture in drug development and toxicology compared to traditional 2D culture systems. This innovation not only enhances predictivity of toxicity and efficacy but also lowers the attrition rate in drug research by allowing a more robust assessment before potential medications progress to pre-clinical animal testing and clinical trials. The focus on advanced products such as 3D Cell Culture Plates underscores the commitment of major companies to staying at the forefront of technological advancements in the dynamic cell culture plates market.

In March 2021, CELLINK AB, a bioprinting company headquartered in Sweden, completed the acquisition of MatTek Corporation, the UK-based life sciences company. The financial details of this acquisition were not disclosed. This strategic move by CELLINK AB aims to strengthen its standing in the fields of bioprinting, multi-omics, cell line development, and diagnostics. Additionally, this acquisition provides CELLINK AB with access to proprietary 3D human-derived tissue and disease models. MatTek Corporation specializes in offering human tissue models and glass-bottom multi-well culture plates, which aligns with CELLINK AB's objectives in advancing its capabilities in biotechnology and life sciences.

Major companies operating in the cell culture plates market report are Thermo Fisher Scientific Inc., USA Scientific Inc., Merck KGaA, Corning Inc., Lonza Group AG, PerkinElmer Inc., VWR International LLC, Sartorius AG, Bio-Rad Laboratories Inc., Sumitomo Bakelite Co. Ltd., Eppendorf AG, Greiner Bio-One International GmbH, Sarstedt AG & Co., Stemcell Technologies, Greiner Bio-One North America Inc., BioLegend Inc., Porvair PLC, Brand GmbH & Co KG, Cell Signaling Technology, MatTek Corporation, Himedia Laboratories Pvt. Ltd., Celltreat Scientific Products, Crystalgen Inc., TPP Techno Plastic Products AG, Jet Bio-Filtration Co. Ltd., Zhejiang Sorfa Life Science Research Co. Ltd, Wuxi NEST Biotechnology Co. Ltd, Socal Biomed LLC, Cellvis, Cole-Parmer India Pvt. Ltd.

North America was the largest region in the cell culture plates market in 2023. The regions covered in the cell culture plates market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the cell culture plates market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Italy, Spain, Canada.

The primary categories of cell culture plates include standard, coated, and specialty variants. Standard cell culture plates are constructed from materials such as borosilicate glass or transparent polymers, allowing distortion-free microscopic observation. They are specifically used for cultivating adherent cell lines. These plates are typically made from polystyrene, glass, or other materials and offer treated and untreated surfaces suitable for applications in drug discovery and development, biopharmaceutical production, tissue engineering, regenerative medicine, and other scientific endeavors. They are utilized across various industries including research institutes, pharmaceutical and biotechnology companies, as well as diagnostic laboratories.

The cell culture plates research report is one of a series of new reports that provides cell culture plates market statistics, including the cell culture plates industry's global market size, regional shares, competitors with cell culture plates market share, detailed cell culture plates market segments, market trends and opportunities, and any further data you may need to thrive in the cell culture plates industry. This cell culture plates market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The cell culture plates market consists of sales of T-flasks, erlenmeyer flasks, dishes plate, tubes and roller bottles. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).


The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.